Moreover, given the level of angst such a decision would inevitably cause (both to shareholders and them as a management team), you would think it wasn't taken lightly.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025